Contact
/
Home
/
About
Team
Portfolio
Exit History
News
About
Team
Portfolio
Exit History
News
Advent Life Sciences
Advent Life Sciences
Page 7 of 24
<< Start
< Prev
2
3
4
5
6
7
8
9
10
11
Next >
End >>
04.06.2020
Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy
Press Release
04.06.2020
Axonics® Announces U.S. Food & Drug Administration Approval of Wireless Patient Remote Control with SmartMRI Technology
Press Release
21.05.2020
Amphista Therapeutics appoints leading protein degradation pioneer, Ian Churcher as CSO
Press Release
13.05.2020
Artax Biopharma Appoints Joseph Lobacki as Chief Executive Officer, Announces Expanded Management Team
Press Release
23.04.2020
Nalu Medical, Inc. Appoints New Chief Executive Officer: Earl R. Fender Joins as President & CEO
Press Release
20.04.2020
Zikani Therapeutics Completes Series A-1 Funding
Press Release
17.04.2020
Highlight Therapeutics announces name change from Bioncotech and launch of new website
Press Release
17.04.2020
Highlight Therapeutics appoints Dr. Carlos Paya as Executive Chairman
Press Release
15.04.2020
Advent Life Sciences Continues Support of Innovation in Life Sciences with the Launch of Two New Cancer Companies
Press Release
15.04.2020
PIC Therapeutics Raises $5 Million to Advance Development of Small Molecules That Selectively Modulate eIF4E
Press Release
©2022 Advent Life Sciences